Moderna Announces Expansion of BARDA Agreement to Support Larger Phase 3 Program
Additional funding to support expanded mRNA-1273 clinical development plan including 30,000 participant…
Biocon’s psoriaris injection okayed for emergency use on Covid-19 patients; Co to launch drug at 8,000 rupees per vial
Amritsar, NFAPost: Biocon Ltd’s Itolizumab, a drug used to cure skin ailment…
